Magenta Therapeutics
(NASDAQ) MGTA
Magenta Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.04M
Net Income (TTM)
$162.34M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MGTA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Magenta Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
92
CEO
Marino Garcia, MBA
Website
dianthustx.comHeadquarters
Cambridge, MA 02139, US
MGTA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-87%
Net Income Margin
-80%
Return on Equity
-39%
Return on Capital
-36%
Return on Assets
-31%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$177.93M
EBITDA
$177.93M
Operating Cash Flow
$129.06M
Capital Expenditure
$213.00K
Free Cash Flow
$129.27M
Cash & ST Invst.
$404.30M
Total Debt
$1.39M
Magenta Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$284.00K
-95.4%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
67
N/A
Net Income
$64.43M
-99.3%
EBITDA
$69.54M
-93.4%
Quarterly Fundamentals
Net Cash
$402.91M
+47.2%
Accounts Receivable
$52.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.02M
-13.0%
Short Term Debt
$367.00K
+14.7%
Return on Assets
-30.58%
N/A
Return on Invested Capital
-35.57%
N/A
Free Cash Flow
$47.12M
-147.3%
Operating Cash Flow
$46.98M
-142.8%